A wearable artificial kidney and two other devices to treat renal failure will get fast-track reviews under a program U.S. regulators say can cut the time it takes to get “breakthrough” medical technology to market.
The Food and Drug Administration chose the three devices -- a valve system, an implant and the artificial kidney -- from 32 applications competing to be in the expedited-review program, the agency said in a statement today. The FDA proposed the Innovation Pathway, a priority review process for “new, breakthrough medical devices,” in February 2011.
SparkPeople, SparkCoach, SparkPages, SparkPoints, SparkDiet, SparkAmerica, SparkRecipes, DailySpark, and other marks are trademarks of SparkPeople, Inc. All Rights Reserved.
SPARKPEOPLE is a registered trademark of SparkPeople, Inc. in the United States, European Union, Canada, and Australia. All rights reserved.